Coave Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$33M

Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.